Recently developed ultrasensitive assays capable of detecting C-peptide under 5 pmol/l now allow very low levels of C-peptide to be detected in patients with long-standing type 1 diabetes. Most patients with long-duration type 1 diabetes continue to secrete very low levels of endogenous insulin, which increase after meals. This is consistent …
Read More »Diabetes In Control
New Nutrition Guidelines from the ADA: One Size Doesn’t Fit All
Healthy eating is encouraged for all individuals, but especially for those with diabetes….
Read More »Beta-cells Don’t Quit Completely in Diabetic Patients
Patients with long-standing type 1 diabetes still make small amounts of insulin….
Read More »Does Retirement Affect Adherence to Medications?
There is a decline in adherence to medication after retirement among men and women with hypertension and men with type 2 diabetes….
Read More »BG Control in Diabetic Patients Undergoing Surgical Wound Closure
Complications from surgical wound closure occur three times higher in diabetic patients with high blood glucose levels….
Read More »Combination Drug Shows Lower Heart Risk
Rosiglitazone plus exenatide shows lower percentage of MI….
Read More »Vitamin D Supplementation Reduces Insulin Resistance in T2DM
Cholesterol levels unchanged….
Read More »Antidepressant May Affect Glucose Metabolism
Antidepressants can worsen glycemic control and/or induce hyperglycemia….
Read More »Triple Drug Regimen Tops Conventional Treatment In New-onset Diabetes
Triple-drug regimen of metformin, exenatide, and pioglitazone at the onset of type 2 diabetes decreased 2-year treatment failure rates by 84%….
Read More »Daytime Sleepiness Increases the Risk for Severe Hypoglycemia
Patients with diabetes who are excessively sleepy during the day may be at a higher risk for hypoglycemia….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.